Prolidase activity and oxidative stress in patients with schizophrenia: A preliminary study

Journal of the Pakistan Medical Association

Volumn 65, Issue 2, 2015, Pages 131-135

  Bahceci, Bulent ^a   Bagcioglu, Erman ^b   Kokacya, Mehmet Hanefi ^c   Dilek, Aziz Ramazan ^a   Bahceci, Ilkay ^a   Selek, Salih ^d  

^a RECEP TAYYIP ERDOGAN UNIVERSITY   (Turkey)

^b AFYON KOCATEPE UNIVERSITY   (Turkey)

^c MUSTAFA KEMAL UNIVERSITY   (Turkey)

^d Education and Agencies Hospital   (Turkey)

Author keywords

Glutamat; Prolidase activity; Proline; Schizophrenia

Indexed keywords

HYDROGEN PEROXIDE; PROLINE DIPEPTIDASE; DIPEPTIDASE; GLUTAMIC ACID;

ADULT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE SEVERITY; DSM-IV; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; OUTPATIENT; OXIDATIVE STRESS; POSITIVE AND NEGATIVE SYNDROME SCALE; SCHIZOPHRENIA; ENZYMOLOGY; METABOLISM; PHYSIOLOGY; SYNAPTIC TRANSMISSION; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; DIPEPTIDASES; FEMALE; GLUTAMIC ACID; HUMANS; MALE; OXIDATIVE STRESS; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION; YOUNG ADULT;

EID: 84928237680     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Berstein HG, Bogerts B, Keilhoff. The many faces of nitric oxide in schizophrenia. A review. Schizophr Res 2005;78:69-86.
2. Harris LW, Guest PC, Wayland MT, Umrania Y, Krishnamurthy D, Rahmounne H, et al. Schizophrenia: Metabolic aspects of aetiology, diagnosis and future treatment strategies. Psychoneuroendocrinology 2012;38:752-66.
3. Kurien BT, Patel NC, Porter AC, D'Souza A, Miller D, Matsumoto H, et al, Scofield RH. Prolidase deficiency and the biochemical assays used in its diagnosis. Anal Biochem 2006;349:165-75.
4. Zanaboni G, Dyne KM, Rossi A, Monafo V, Cetta G. Prolidase deficiency: biochemical study of erythrocyte and skin fibroblast prolidase activity in Italian patients. Haematologica 1994;79:13-8.
5. Palka JA. The role of prolidase as an enzyme participating in the metabolism of collagen. RoczAkad Med Bialymst 1996;41:149-60.
6. Wu G, Bazer FW, Burghardt RC, Johnson GA, Knabe DA, Li P, et al. Proline and hydroxyproline metabolism: implications for animal and human nutrition. Amino Acids 2011;40:1053-63.
7. Chi H, Liu G, Tong J, Nakayama K, Yamashita K, Kitaoka N, et al. Aktivity of prolidaseisoenzymes in the rat brain: subcellular and regional distribution during development. Brain Res 2009;1303:8-14.
8. Wyse AT, Netto CA. Behavioral and neurochemical effects of proline. Metab Brain Dis 2011;26:159-72.
9. Mitsubuchi H, Nakamura K, Matsumoto S, Endo F. Inborn errors of proline metabolism. J Nutr 2008;138:2016S-2020S.
10. Hui KS, Lajtha A. Prolidase activity in brain: comparison with other organs. J Neurochem 1978; 30:321-7.
11. Henzi V, Reichling DB, Helm SW, Mac Dermott AB. L-proline activates glutamate and glyncine receptors in cultured rat dorsal horn neurons. Mol Pharmacol 1992;41:793-810.
12. Ortiz JG, Cordero ML, Rosado A. Proline-glutamate interactions in the CNS. Prog Neuropsychopharmacol Biol Psychiatry 1997;21:141-52.
13. Martin D, Ault B, Nadler JV. NMDA receptor-mediated depolarizing action of proline on CA1 pyramidal cells. Eur J Pharmacol 1992;219:59-6.
14. Cohen SM, Nadler JV. Proline-induced potentiation of glutamate transmission. Brain Res 1997;761:271-82.
15. Tsai G, Coyle JT. Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol 2002;42:165-79.
16. Paz RD, Tardito S, Atzori M, Tseng KY. Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology. Eur Neuropsychopharmacol 2008;18:773-86.
17. Nudmamud S, Reynolds GP. Increased density of glutamate/Nmethyl- D-aspartate receptors in superior temporal cortex in schizophrenia. Neurosci Lett.2001;304:9-12.
18. Kantrowitz JT, Javitt DC. N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res Bull 2010;83:108-21.
19. Selek S, Altindag A, Saracoglu G, Celik H, Aksoy N. Prolidase activity and its diagnostic performance in bipolar disorder. J Affect Disord.2011;129:84-6.
20. Arikanoglu A, Akil E, Varol S, Yucel Y, Yuksel H, Cevik MU, et al. Relationship of cognitive performance with prolidase and oxidative stress in Alzheimer disease. Neuro Sci 2013;34:2117-21.
21. Palomino A, Gonzalez-Pinto A, Aldama A, Gonzalez-Gomez C, Mosquera F, Gonzalez-Garcia G, et al. Decreased levels of plasma glutamate in patients with firs-episode schizophrenia and bipolar disorder. Schizophr Res 2007;95:174-8.
22. Cowburn RF, Hardy JA, Roberts PJ. Glutamatergic neurotransmission in Alzheimer's disease. BiochemSoc Trans 1990;18:390-2.
23. Hilali N, Vural M, Camuzoglu H, Camuzoglu A, Aksoy N. Increased prolidase activity and oxidative stress in PSOS. Clin Endocrinol (Oxf) 2013;79:105-10.
24. Toy H, Camuzoglu H, Arioz DT, Kurt S, Celik H, Aksoy N. Serum prolidase activity and oxidative stressmarkers in pregnancieswith intrauterine growth restricted infants. J Obstet Gynaecol Res 2009;35:1047-53.
25. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders. Washington DC: American Psychiatric Press, Inc, 1997.
26. Kostakoglu AE, Batur S, Tiryaki A. Pozitifve Negatif Sendrom Ölçeginin (PANSS) Türkçe Uyarlamasinin Geçerlikve Güvenilirligi. Türk Psikoloji Dergisi 1999; 14: 23-32.
27. Erel O. A novel automated metdod to measure total antioxidant response aganist potent free radical reactions. Clin Biochem.2004;37:112-9.
28. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103-11.
29. Harma MI, Harma M, Erel O. Measuring plasma oxidative stres biomarkers in sport medicine. Eur J Appl Physiol 2006;97:505.
30. Crump FT, Fremeau RT, Craig AM. Localization of the brain-specific high-affinity I-proline transporter in cultured hippocampal neurons:molecular heterogeneity of synaptic terminals. Mol Cell Neurosci 1999;13:25-39.
31. Cohen SM, Nadler JV. Proline-induced inhibition of glutamate release in hippocampal area CA 1. Brain Res 1997;769:333-9.
32. Vorstman JA, Turetsky BI, Sijmens- Morcus ME, de Sain MG, Dorland B, Sprong M, et al. Proline affects brain function in 22q11DS children with the low activity COMT 158 allele. Neuropsychopharmacology 2009;34:739-46.
33. Moreira JCF, Wannmacher CMD, Costa SM, Wajner M. Effect of proline administration on rat behavior in aversive and nonaversive task. Pharmacmacol Biochem Behav 1989;32:885-90.
34. Raux G, Bumsel E, Hecketsweiler B, Van Amelsvoort T, Zinkstok J, Manouvrier-Hanu S, et al. Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. Hum Mol Genet 2007;16:83-911.
35. Lupi A, Tenni R, Rossi A, Cetta G, Forlino A 2008. Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations. Amino Acids 2008;35:739-52.
36. Jacquet H, Raux G, Thibaut F, Hecketsweiler B, Houy E, Demilly C, et al. PRODH mutations and hyperprolinemia in a subset of schizophrenic patients. Hum Mol Genet 2002;11:2243-9.
37. Jacquet H, Demily C, Houy E, Hecketsweiler B, Bou J, Raux G, et al. Hyperprolinemia is a risk factor schizoaffective disorder. Mol Psychiatry 2005;10;479-85.
38. Cleland CL, Read L L, Beraldi AN, Bart CP, Pappas CA, Panek LJ et al. Evidence for association of hyperprolinemia with schizophrenia and ameasure of clinical outcome. Schizophr Res 2011; 131:139-145.
39. Akyol O, Herken H, Uz E, Fadillioglu E, Unal S, Sogut S, et al. The indices of endogenous oxidative and antiocidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:995-1005.
40. Bitanihirwe BK, Woo TU. Oxidative stress in schizophrenia: an integrated approach. Neurosci Bio behav Rev 2011;35:878-93.
41. Fendri C, Mechri A, Khiari G, Othman A, Kerkeni A, Gaha L. Oxidative stress involvement in schizophrenia pathophysiology: a review. 2006;32:244-52.
42. Camuzoglu H, Arioz DT, Toy H, Kurt S, Celik H, Aksoy N. Assessment of preoperative serum prolidase activity in epithelial ovarian canser: Eur J Obstet Gynecol Reprod Biol 2009;147:97-100.
43. Aslan M, Nazligul Y, Horoz M, Bolukbas C, Bolukbas FF, Aksoy N, et al. Serum prolidase activity and oxidative status in Helicobacter pylori. Clin Biochem 2007;40:37-40.
44. Rabus M, Demirbag R, Yildiz A, Tezcan O, Yilmaz R, Ocak AR, et al. Association of prolidase activity, oxidative parameters, and presence of atrial fibrillation in patients with mitral stenosis. Arch Med Res 2008;39:519-24.
45. Sullivan EM, O'Donnell P. Inhibitory interneurons, oxidative stress, and schizophrenia. Schizophr Bull 2012;38:373-6.
46. Wood SJ, Yucel M, Pantelis C, Berk M. Neurobiology of schizophrenia spectrumdisorders: the role of oxidative stress. Ann Acad Med Singapore.2009;38:396-6.
47. Delwing D, Bavaresco CS, Wannmacher CM, Wajner M, Dutra-Filho CS, Wyse AT. Proline induces oxidative stress in cerebral cortex of rats. Int J Neurosci 2003;21:105-10.